History of the cholesterol controversy in Britain

QJM: An International Journal of Medicine

Volumn 102, Issue 2, 2009, Pages 81-86

  Thompson, G R ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; CLOFIBRATE; COLESTYRAMINE; COMPACTIN; CORN OIL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MEVINOLIN; PHYTOSTEROL; SIMVASTATIN; SOYBEAN OIL;

ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL SYNTHESIS; CLINICAL TRIAL; CORONARY RISK; DIETARY INTAKE; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; DRUG SCREENING; DRUG SYNTHESIS; ELECTROCARDIOGRAPHY; HEALTH PROMOTION; HISTORY OF MEDICINE; HUMAN; HYPERCHOLESTEROLEMIA; INCIDENCE; ISCHEMIC HEART DISEASE; LOW FAT DIET; MORTALITY; NUTRITIONAL ASSESSMENT; PATHOGENESIS; POSTGRADUATE EDUCATION; PRIORITY JOURNAL; REVIEW; RHABDOMYOLYSIS; SECONDARY PREVENTION; SUGAR INTAKE; TREATMENT RESPONSE; UNITED KINGDOM;

EID: 58949099398     PISSN: 14602725     EISSN: 14602393     Source Type: Journal    
DOI: 10.1093/qjmed/hcn158     Document Type: Review

References (48)

1. Reynolds LA, Tansey EM, eds. Cholesterol, atherosclerosis and coronary disease in the UK, 1950-2000. In: Wellcome Witnesses to Twentieth Century Medicine, Vol. 27. 2006:4. London. The Wellcome Trust Centre for the History of Medicine at UCL.
2. Oliver MF, Boyd GS. The plasma lipids in coronary artery disease. Br Heart J 1953; 15:387-92.
3. Rose GA, Thomson WB, Williams RT. Corn oil in treatment of ischaemic heart disease. Br Med J 1965; 1:1531-3.
4. Research Committee. Low-fat diet in myocardial infarction. A controlled trial. Lancet 1965; 2:501-4.
5. Report of a Research Committee to the Medical Research Council. Controlled trial of soya-bean oil in myocardial infarction. Lancet 1968; 2:693-9.
6. Oliver MF. Further observations on the effects of atromid and of ethyl chlorophenoxyisobutyrate on serum lipid levels. J Atheroscler Res 1963; 3:427-44.
7. Report by a Research Committee of the Scottish Society of Physicians. Ischaemic heart disease: A secondary prevention trial using clofibrate. Br Med J 1971; 4:775-84.
8. Five-year study by a group of physicians of the Newcastle upon Tyne region. Trial of clofibrate in the treatment of ischaemic heart disease. Br Med J 1971; 4:767-75.
9. Report from the Committee of Principal Investigators. A co-operative trial in the primary prevention of ischaemic heart disease using clofibrate. Br Heart J 1978; 40:1069-118.
10. Lipid Research Clinics Program. The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in incidence of coronary heart disease. JAMA 1984; 251:351-64.
11. Lipid Research Clinics Program. The Lipid Research Clinics Coronary Primary Prevention Trial results. II. The relationship of reduction in incidence of coronary heart disease to cholesterol lowering. JAMA 1984; 251:365-74.
12. Yudkin J. Why suspicion falls on sugar as a major cause of heart disease. The Times 1974; 11 July:16.
13. Yudkin J. Sucrose and cardiovascular disease. Proc Nutr Soc 1972; 31:331-7.
14. Yudkin J, Roddy J. Levels of dietary sucrose in patients with occlusive atherosclerotic disease. Lancet 1964; 41:6-8.
15. Yudkin J, Morland J. Sugar intake and myocardial infarction. Am J Clin Nutr 1967; 20:503-6.
16. Dietary sugar intake in men with myocardial infarction. Report to the Medical Research Council by its working party on the relationship between dietary sugar intake and arterial disease. Lancet 1970; 2:1265-71.
17. Booth C. Sir John McMichael. Lancet 1993; 341:686.
18. Farewell at Hammersmith. Br Med J 1966; 6:320.
19. McMichael J. Diet and exercise in coronary heart-disease. Lancet 1974; 1:1340-1.
20. McMichael J. Prevention of coronary heart-disease. Lancet 1976; 2:569.
21. McMichael J. Risk factors in coronary heart-disease. Lancet 1977; 5:304.
22. Rose G, Reid DD, McCartney P. Risk factors in coronary heart-disease. Lancet 1977; 5:304.
23. McMichael J. Fats and atheroma: An inquest. Br Med J 1979; 1 173-5.
24. McMichael J. Fats and arterial disease. Am Heart J 1979; 98 409-12.
25. Department of Health and Social Security. Report on Health and Society Subjects. 7. Diet and Coronary Heart disease. Report of the Advisory Panel of the Committee on Medical Aspects of Food Policy (Nutrition) on diet in relation to Cardiovascular and Cerebrovascular Disease. London: HMSO, 1974.
26. Mitchell JRA. Diet and coronary heart disease-a British point of view. Adv Exp Med Biol 1977; 82:823-7.
27. Department of Health and Social Security. Report on Health and Society Subjects. 28. Diet and Cardiovascular Disease. Committee on Medical Aspects of Food Policy. Report of the Panel on Diet in Relation to Cardiovascular Disease. London: HMSO, 1984.
28. Reynolds LA, Tansey EM (Eds). Cholesterol, atherosclerosis and coronary disease in the UK, 1950-2000. Wellcome Witnesses to Twentieth Century Medicine, Vol 27, 2006:62. London. The Wellcome Trust Centre for the History of Medicine at UCL.
29. Mitchell JRA. What constitutes evidence on the dietary prevention of coronary heart disease? Cosy beliefs or harsh facts? Int J Cardiol 1984; 5:287-98.
30. Obituary. Mitchell JRA. Br Med J 1991; 302:843.
31. Endo A, Kuroda M, Tsujita Y. ML-236A, ML-236B, and ML-236C, new inhibitors of cholesterogenesis produced by Penicillium citrinum. J Antibiot (Tokyo) 1976; 29:1346-8.
32. Brown AG, Smale TC, King TJ, Hasenkamp R, Thompson RH. Crystal and molecular structure of compactin, a new antifungal metabolite from Penicillium brevicompactum. J Chem Soc [Perkin 1] 1976; 11:1165-70.
33. Fears R, Richards DH, Ferres H. The effect of compactin, a potent inhibitor of 3-hydroxy-3- methylglutaryl coenzyme-A reductase activity, on cholesterogenesis and serum cholesterol levels in rats and chicks. Atherosclerosis 1980; 35:439-49.
34. Betteridge DJ, Krone W, Reckless JPD, Galton DJ. Compactin inhibits cholesterol synthesis in lymphocytes and intestinal mucosa from patients with familial hypercholesterolaemia. Lancet 1978; 2:1342-3.
35. Yamamoto A, Sudo H, Endo A. Therapeutic effects of ML-236B in primary hypercholesterolemia. Atherosclerosis 1980; 35:259-66.
36. Alberts AW, Chen J, Kuron G, Hunt V, Huff J, Hoffman C, et al. Mevinolin: A highly potent competitive inhibitor of hydroxymethylglutaryl- coenzyme A reductase and a cholesterol-lowering agent. Proc Natl Acad Sci USA 1980; 77:3957-61.
37. Tobert JA. Lovastatin and beyond: The history of the HMGCoA reductase inhibitors. Nat Rev Drug Discov 2003; 2:517-26.
38. Thompson GR, Ford J, Jenkinson M, Trayner I. Efficacy of mevinolin as adjuvant therapy for refractory familial hypercholesterolaemia. Q J Med 1986; 60:803-11.
39. Oliver MF. Reducing cholesterol does not reduce mortality. J Am Coll Cardiol 1988; 12:814-7.
40. Muldoon MF, Manuck SB, Matthews KA. Lowering cholesterol concentrations and mortality: A quantitative review of primary prevention trials. Br Med J 1990; 301:309-14.
41. Davey Smith G, Pekkanen J. Should there be a moratorium on the use of cholesterol lowering drugs?. Br Med J 1992; 304:431-4.
42. Law MR, Thompson SG, Wald NJ. Assessing possible hazards of reducing serum cholesterol. Br Med J 1994; 308:373-9.
43. Scandinavian Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S). Lancet 1994; 344:1383-9.
44. Oliver M, Poole-Wilson P, Shepherd J, Tikkanen M. Lower patients' cholesterol now. Br Med J 1995; 310:1280-1.
45. Baigent C, Keech A, Kearney PM, Blackwell L, Buck G, Pollicino C, et al. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet 2005; 366:1267-78.
46. Shepherd J, Cobbe S, Ford I, Isles CG, Lorimer AR, MacFarlane PW, et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group. N Engl J Med 1995; 333:1301-7.
47. Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20536 high-risk individuals: A randomised placebo-controlled trial. Lancet 2002; 360:7-22.
48. Pollak OJ. Reduction of blood cholesterol in man. Circulation 1953; 7:702-6.